Biora Therapeutics Overview
Biora Therapeutics (BIOR) has a P/E ratio of 0.0, below the Healthcare sector average of 27.42.
Get informed when a big investor buys or sells
+ Follow0.00
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, BIOR shows a P/E ratio of 0.0. That is below the Healthcare sector average of 27.42. Scroll down for historical charts and peer comparison views.
The Healthcare sector average P/E ratio is about 27.42. Biora Therapeutics is at 0.0, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how BIOR stacks up against individual peers as well.
Investors watch BIOR's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Biora Therapeutics's latest reading is 0.0. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has Biora Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently 0.0) with ownership activity and broader fundamentals.
The Healthcare average P/E ratio is about 27.42, while BIOR is at 0.0. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
